Your browser doesn't support javascript.
loading
The association of clinical outcome and peripheral T-cell subsets in metastatic colorectal cancer patients receiving first-line FOLFIRI plus bevacizumab therapy.
Roselli, Mario; Formica, Vincenzo; Cereda, Vittore; Jochems, Caroline; Richards, Jacob; Grenga, Italia; Orlandi, Augusto; Ferroni, Patrizia; Guadagni, Fiorella; Schlom, Jeffrey.
Afiliação
  • Roselli M; Medical Oncology, Department of Systems Medicine, Tor Vergata University Clinical Center, University of Rome Tor Vergata , Rome, Italy.
  • Formica V; Medical Oncology, Department of Systems Medicine, Tor Vergata University Clinical Center, University of Rome Tor Vergata , Rome, Italy.
  • Cereda V; Medical Oncology, Department of Systems Medicine, Tor Vergata University Clinical Center, University of Rome Tor Vergata , Rome, Italy.
  • Jochems C; Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health , Bethesda, MD, USA.
  • Richards J; Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health , Bethesda, MD, USA.
  • Grenga I; Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health , Bethesda, MD, USA.
  • Orlandi A; Anatomic Pathology Institute, Department of Biomedicine and Prevention, University of Rome Tor Vergata , Rome, Italy.
  • Ferroni P; Department of Human Sciences and Quality of Life Promotion, San Raffaele Roma Open University , Rome, Italy.
  • Guadagni F; Department of Human Sciences and Quality of Life Promotion, San Raffaele Roma Open University, Rome, Italy; Interinstitutional Multidisciplinary Biobank (BioBIM), IRCCS San Raffaele Pisana, Rome, Italy.
  • Schlom J; Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health , Bethesda, MD, USA.
Oncoimmunology ; 5(7): e1188243, 2016 Jul.
Article em En | MEDLINE | ID: mdl-27622042
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Oncoimmunology Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Oncoimmunology Ano de publicação: 2016 Tipo de documento: Article